Pre-made Isecarosmab benchmark antibody ( Bispecific Single Domains (VH-VH'), anti-ADAMTSL5;ALB therapeutic antibody, Anti-THSD6;FDAHT/HSA/PRO0883/PRO0903/PRO1341 Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-281

Pre-Made Isecarosmab biosimilar, Bispecific Single Domains (VH-VH'), Anti-ADAMTSL5;ALB Antibody: Anti-THSD6;FDAHT/HSA/PRO0883/PRO0903/PRO1341 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-281-1mg 1mg Inquiry
GMP-Bios-ab-281-10mg 10mg Inquiry
GMP-Bios-ab-281-100mg 100mg Inquiry
GMP-Bios-ab-281-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Isecarosmab biosimilar, Bispecific Single Domains (VH-VH'), Anti-ADAMTSL5;ALB Antibody: Anti-THSD6;FDAHT/HSA/PRO0883/PRO0903/PRO1341 therapeutic antibody
INN Name Isecarosmab
TargetADAMTSL5;ALB
FormatBispecific Single Domains (VH-VH')
DerivationBispecific antibody
Species ReactivityHuman
CH1 Isotypena;na
VD LCna;na
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusActive
100% SI StructureNone;None
99% SI StructureNone;None
95-98% SI StructureNone;None
Year Proposed2019
Year Recommended2020
CompaniesMerck
Conditions Approvedna
Conditions ActiveSolid tumours
Conditions Discontinuedna
Development Techna